Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer

Fig. 3

Amplification of CRAd genomes in OvCa cells. The relative amplification of CRAd genome following OvCa cell infection was determined 3 days postinfection using TaqMan qPCR primer/probe to detect viral genome copy number in samples of total DNA isolated from the indicated OvCa cell lines infected with CRAd-IL24, CRAd-ING4, or control CRAd at the MOI of 10 vp/cell. Each bar represents the cumulative mean Ad genome copy number/ng β-actin DNA ± SD (*p ≤ 0.05)

Back to article page